| __timestamp | Amphastar Pharmaceuticals, Inc. | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 28427000 | 293000 |
| Thursday, January 1, 2015 | 37065000 | 1002000 |
| Friday, January 1, 2016 | 41199000 | 888000 |
| Sunday, January 1, 2017 | 43415000 | 19623000 |
| Monday, January 1, 2018 | 57564000 | 30421000 |
| Tuesday, January 1, 2019 | 68853000 | 34794000 |
| Wednesday, January 1, 2020 | 67229000 | 28304000 |
| Friday, January 1, 2021 | 60932000 | 56886000 |
| Saturday, January 1, 2022 | 74771000 | 100894000 |
| Sunday, January 1, 2023 | 73741000 | 159765000 |
Cracking the code
In the ever-evolving landscape of biopharmaceuticals, research and development (R&D) spending is a critical indicator of innovation and future growth. Amphastar Pharmaceuticals, Inc. and Viridian Therapeutics, Inc. have shown distinct trends in their R&D allocations over the past decade. From 2014 to 2023, Amphastar's R&D expenses have grown steadily, peaking in 2022 with a 163% increase from 2014. Meanwhile, Viridian's R&D spending skyrocketed, especially from 2021 to 2023, marking a staggering 54-fold increase since 2014. This surge reflects Viridian's aggressive investment in pioneering therapies. The data highlights a strategic shift in the industry, emphasizing the importance of R&D in maintaining competitive advantage and driving innovation. As these companies continue to invest in R&D, they are not only shaping their futures but also the future of healthcare.
Eli Lilly and Company vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending
AbbVie Inc. vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Regeneron Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.
Bio-Techne Corporation or Viridian Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Corcept Therapeutics Incorporated and Viridian Therapeutics, Inc.
Research and Development Expenses Breakdown: Verona Pharma plc vs Amphastar Pharmaceuticals, Inc.
Analyzing R&D Budgets: ADMA Biologics, Inc. vs Amphastar Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for CRISPR Therapeutics AG and Amphastar Pharmaceuticals, Inc.
Research and Development Investment: Amicus Therapeutics, Inc. vs Viridian Therapeutics, Inc.
R&D Spending Showdown: Soleno Therapeutics, Inc. vs Amphastar Pharmaceuticals, Inc.
Comparing Innovation Spending: Geron Corporation and Viridian Therapeutics, Inc.
Comparing Innovation Spending: Celldex Therapeutics, Inc. and Viridian Therapeutics, Inc.